P95 completes acquisition of Assign DMB, expanding data management and biostatistics services
Acquiring Company
P95
Acquired Company
Assign DMB
Description
P95 BV, a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases, has announced the acquisition of Assign DMB. This acquisition enhances P95's capacity to implement both clinical and non-interventional studies, with a continued focus on vaccines and infectious diseases, reinforcing its position as a world class leader in clinical research globally.
Quick answer
P95 is acquiring Assign DMB, announced September 5, 2024. P95 is based in Leuven, Flemish Brabant, Belgium.
- How much did P95 pay for Assign DMB?
- The deal value was not disclosed.
- What does P95 do?
- P95 is a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases.
- Where are P95 and Assign DMB based?
- P95 is based in Leuven, Flemish Brabant, Belgium. Assign DMB is based in Innsbruck, Tyrol, Austria.
- Who are the decision-makers at P95?
- Fundz holds 1 contact at P95. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Flat Medical strengthens market leadership with acquisition of InjeQ assets, including FDA-Designated Breakthrough Device IQ-Tip® (September 25, 2024)
- KARL STORZ completes acquisition of Asensus Surgical, Inc. to strengthen its position in robotic and digital surgical market (August 22, 2024)
- Lupin strengthens its presence in the South African market through the acquisition of nine leading brands (October 4, 2024)
- Pinnacle Clinical Research acquires Jubilee Clinical Research to strengthen expertise in metabolic and cardiovascular diseases (September 27, 2024)
- Breeze Holdings Acquisition Corp. to merge with YD Biopharma Limited to revolutionize cancer prevention diagnostics (September 25, 2024)
- Vitalograph acquires Morgan Scientific to strengthen US commercial footprint (September 23, 2024)
Who to call at P95, and when
When P95 changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day P95 raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at P95, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at P95. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment P95 makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Assign DMB?
Assign DMB was acquired by P95, based in Leuven. The deal was reported on September 5, 2024. P95 is a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases. P95 is privately held and operates in Biotechnology.
When did P95 acquire Assign DMB?
P95's acquisition of Assign DMB was reported on September 5, 2024. P95 BV, a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases, has announced the acquisition of Assign DMB. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Assign DMB do?
Assign DMB is one of the leading clinical research organisations in Austria offering a broad range of services for all phases of clinical trials. It is privately held, operating in Biotechnology, and is based in Innsbruck.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.